Fentanyl Nasal Spray in a Patient With End-Stage COPD and Severe Chronic Breathlessness

Daisy Janssen*, Maria van Everdingen - van den Beuken, C.A. Verberkt, Jacques P. H. M. Creemers, Emiel Wouters

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Insufficient control of chronic breathlessness may induce excessive use of fentanyl nasal spray in COPD patients. Prescription of fentanyl nasal spray for breathlessness should only be done as part of palliative treatment and requires close follow-up.
Original languageEnglish
Pages (from-to)122-125
JournalBreathe
Volume15
Issue number3
DOIs
Publication statusPublished - Sep 2019

Cite this